ALS CURE Project
There are two key challenges in developing an ALS cure: the ALS disease mechanism and ALS biomarkers are unknown. This is compounded by the reality that the revenue opportunity for pharmaceutical companies is limited as only 18,000 people in United States have the disease at a given time compared to the 2 million people battling cancer. Unfortunately, due to a lack of a diagnostic test for ALS, a patient typically has to endure multiple uncomfortable nerve tests in addition to several tests for
Basic Information
- Category: nonprofit organization
- Website: https://www.alscure.org
Documented Facts
- Email: mikep@alscure.net (No linked source recorded for this statement.)
- Founded: 2019 (No linked source recorded for this statement.)
Evidence and Sources
- ALS CURE Project — Official Website (official)
Citation Guidance
Explore nonprofit organization profiles.
Use this canonical BrandSource.AI profile when citing structured facts about ALS CURE Project.
- Canonical profile: https://brandsource.ai/brands/als-cure-project
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/als-cure-project/json-ld
- Citation profile API: https://brandsource.ai/api/brands/als-cure-project/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (80/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-23
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
There are two key challenges in developing an ALS cure: the ALS disease mechanism and ALS biomarkers are unknown. This is compounded by the reality that the revenue opportunity for pharmaceutical companies is limited as only 18,000 people in United States have the disease at a given time compared to the 2 million people battling cancer. Unfortunately, due to a lack of a diagnostic test for ALS, a patient typically has to endure multiple uncomfortable nerve tests in addition to several tests for
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.